R14 concomitant use of Intra-Aortic Balloon Pump and extra-corporeal membrane oxygenation – a benchtop trial

J. Farag; J. Chong; A. Stephens; S. Gregory; Silvana Francesca Marasco

doi:10.1016/j.hlc.2021.03.172

R14 concomitant use of Intra-Aortic Balloon Pump and extra-corporeal membrane oxygenation – a benchtop trial

J. Farag
, J. Chong
, A. Stephens
, S. Gregory
, Silvana Francesca Marasco

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

VA-ECMO is the mainstay of treatment for refractory cardiogenic shock. However, it has been associated with increased LV loading. The Intra-Aortic Balloon Pump (IABP) has been utilised to assist in weaning of VA-ECMO patients, as some studies have shown an improvement in survival. Yet the evidence on its improvement in LV venting, afterload reduction, coronary and cerebral flow are conflicting, and the procedural risks may outweigh any potential benefit. Our aim was to determine the impact of the addition of an IABP to ECMO in various simulations of cardiac failure.

Original language	English
Article number	S21
Number of pages	1
Journal	Heart Lung and Circulation
Volume	30
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/j.hlc.2021.03.172
Publication status	Published - 2021
Event	Australian and New Zealand Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting 2019 - Hobart, Australia Duration: 7 Nov 2019 → 10 Nov 2019 https://www.heartlungcirc.org/issue/S1443-9506(21)X0006-6

Access to Document

10.1016/j.hlc.2021.03.172

Cite this

@article{e56d56cc4c4a422da5c2f4b23bae3fc4,

title = "R14 concomitant use of Intra-Aortic Balloon Pump and extra-corporeal membrane oxygenation – a benchtop trial",

abstract = "VA-ECMO is the mainstay of treatment for refractory cardiogenic shock. However, it has been associated with increased LV loading. The Intra-Aortic Balloon Pump (IABP) has been utilised to assist in weaning of VA-ECMO patients, as some studies have shown an improvement in survival. Yet the evidence on its improvement in LV venting, afterload reduction, coronary and cerebral flow are conflicting, and the procedural risks may outweigh any potential benefit. Our aim was to determine the impact of the addition of an IABP to ECMO in various simulations of cardiac failure.",

author = "J. Farag and J. Chong and A. Stephens and S. Gregory and Marasco, \{Silvana Francesca\}",

year = "2021",

doi = "10.1016/j.hlc.2021.03.172",

language = "English",

volume = "30",

journal = "Heart Lung and Circulation",

issn = "1443-9506",

publisher = "Elsevier",

number = "Supplement 1",

note = "Australian and New Zealand Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting 2019, ANZSCTS 2019 ; Conference date: 07-11-2019 Through 10-11-2019",

url = "https://www.heartlungcirc.org/issue/S1443-9506(21)X0006-6",

}

TY - JOUR

T1 - R14 concomitant use of Intra-Aortic Balloon Pump and extra-corporeal membrane oxygenation – a benchtop trial

AU - Farag, J.

AU - Chong, J.

AU - Stephens, A.

AU - Gregory, S.

AU - Marasco, Silvana Francesca

PY - 2021

Y1 - 2021

N2 - VA-ECMO is the mainstay of treatment for refractory cardiogenic shock. However, it has been associated with increased LV loading. The Intra-Aortic Balloon Pump (IABP) has been utilised to assist in weaning of VA-ECMO patients, as some studies have shown an improvement in survival. Yet the evidence on its improvement in LV venting, afterload reduction, coronary and cerebral flow are conflicting, and the procedural risks may outweigh any potential benefit. Our aim was to determine the impact of the addition of an IABP to ECMO in various simulations of cardiac failure.

AB - VA-ECMO is the mainstay of treatment for refractory cardiogenic shock. However, it has been associated with increased LV loading. The Intra-Aortic Balloon Pump (IABP) has been utilised to assist in weaning of VA-ECMO patients, as some studies have shown an improvement in survival. Yet the evidence on its improvement in LV venting, afterload reduction, coronary and cerebral flow are conflicting, and the procedural risks may outweigh any potential benefit. Our aim was to determine the impact of the addition of an IABP to ECMO in various simulations of cardiac failure.

U2 - 10.1016/j.hlc.2021.03.172

DO - 10.1016/j.hlc.2021.03.172

M3 - Meeting Abstract

SN - 1443-9506

VL - 30

JO - Heart Lung and Circulation

JF - Heart Lung and Circulation

IS - Supplement 1

M1 - S21

T2 - Australian and New Zealand Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting 2019

Y2 - 7 November 2019 through 10 November 2019

ER -